Yunnan Baiyao Group Co., Ltd.
1 clinical trials · Sponsor
◉ Watch Yunnan Baiyao Group Co., Ltd.
| Record | Firm | Date |
|---|---|---|
| An Phase I/IIa Clinical Study to Evaluate the Safety/Tolerability, Pharmacokinetics and Preliminary Efficacy of INB301 Injection in Patients With Cancer Cachexia (NCT07584057) | Yunnan Baiyao Group Co., Ltd. | 2026-05-01 |
Track Yunnan Baiyao Group Co., Ltd. automatically
Every clearance here is in the API, with alerts when new ones post.